
Ocular Therapeutix OCUL
$ 6.87
2.5%
Country |
|
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
187 M |
Market Cap[1] |
$ 1.29 B |
EBITDA (LTM) |
$ -266 M |
P/E (LTM) |
-7.492958 |
P/S (LTM) |
38.348624 |
EPS (LTM) |
-1.42 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Keros Therapeutics
KROS
|
$ 10.66 | 0.45 % | $ 397 M | Nasdaq Global Select Market | ||
|
XBiotech
XBIT
|
$ 2.12 | 1.67 % | $ 64.6 M | Nasdaq Global Select Market | ||
|
Xenon Pharmaceuticals
XENE
|
$ 33.49 | 1.27 % | $ 2.65 B | Nasdaq Global Select Market | ||
|
Xeris Pharmaceuticals
XERS
|
$ 10.31 | 2.38 % | $ 1.65 B | Nasdaq Global Select Market | ||
|
X4 Pharmaceuticals
XFOR
|
$ 2.59 | 0.19 % | $ 110 M | Nasdaq Capital Market | ||
|
Kodiak Sciences
KOD
|
$ 85.75 | 0.64 % | $ 4.56 B | Nasdaq Global Market,SPB | ||
|
22nd Century Group
XXII
|
$ 0.34 | 0.98 % | $ 62.6 K | NYSE American | ||
|
Halozyme Therapeutics
HALO
|
$ 121.84 | 0.27 % | $ 14.6 B | Nasdaq Global Select Market,SPB | ||
|
Arvinas
ARVN
|
$ 6.97 | 1.12 % | $ 494 M | Nasdaq Global Select Market,SPB | ||
|
Zai Lab Limited
ZLAB
|
$ 23.19 | 0.79 % | $ 25.4 B | Nasdaq Global Select Market | ||
|
Zentalis Pharmaceuticals
ZNTL
|
$ 2.13 | 0.83 % | $ 153 M | Nasdaq Global Market | ||
|
Autolus Therapeutics plc
AUTL
|
$ 1.6 | 1.78 % | $ 426 M | Nasdaq Global Select Market | ||
|
BridgeBio Pharma
BBIO
|
$ 66.39 | 3.37 % | $ 12.7 B | Nasdaq Global Select Market,SPB | ||
|
PMV Pharmaceuticals
PMVP
|
$ 1.21 | 4.03 % | $ 63.6 M | Nasdaq Global Select Market | ||
|
Harmony Biosciences Holdings
HRMY
|
$ 37.95 | 0.17 % | $ 2.18 B | Nasdaq Global Select Market | ||
|
Kazia Therapeutics Limited
KZIA
|
$ 7.25 | 0.54 % | $ 111 M | Nasdaq Global Select Market | ||
|
CNS Pharmaceuticals
CNSP
|
$ 4.85 | 3.08 % | $ 2.15 M | Nasdaq Capital Market | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | ||
|
MacroGenics
MGNX
|
$ 3.25 | 1.81 % | $ 205 M | Nasdaq Global Select Market | ||
|
iBio
IBIO
|
$ 0.77 | 0.63 % | $ 80.1 M | NYSE American | ||
|
Cytokinetics, Incorporated
CYTK
|
$ 61.95 | 0.77 % | $ 7.44 M | Nasdaq Global Select Market,SPB | ||
|
Immunome
IMNM
|
$ 16.47 | 1.16 % | $ 1.44 B | Nasdaq Global Select Market | ||
|
Immuron Limited
IMRN
|
$ 0.98 | 0.49 % | $ 226 M | Nasdaq Global Select Market | ||
|
Moderna
MRNA
|
$ 218.01 | 4.51 % | $ 84.8 B | Nasdaq Global Select Market,SPB | ||
|
InMed Pharmaceuticals
INM
|
$ 1.32 | 0.38 % | $ 5.5 M | Nasdaq Capital Market | ||
|
INmune Bio
INMB
|
$ 1.57 | 3.12 % | $ 38.9 M | Nasdaq Capital Market | ||
|
Inovio Pharmaceuticals
INO
|
$ 0.99 | 5.48 % | $ 46.4 M | Nasdaq Global Select Market | ||
|
Insmed Incorporated
INSM
|
$ 96.27 | 1.45 % | $ 19.2 B | Nasdaq Global Select Market | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$ 10.78 | 4.62 % | $ 697 M | NYSE | ||
|
Biogen
BIIB
|
$ 232.65 | 0.1 % | $ 34.1 B | Nasdaq Global Select Market,SPB | ||
|
BioVie
BIVI
|
$ 1.2 | 6.19 % | $ 1.77 M | Nasdaq Capital Market | ||
|
Ionis Pharmaceuticals
IONS
|
$ 42.94 | 3.33 % | $ 6.87 B | Nasdaq Global Select Market,SPB | ||
|
Innate Pharma S.A.
IPHA
|
$ 1.43 | 0.54 % | $ 128 M | Nasdaq Global Select Market | ||
|
NextCure
NXTC
|
$ 6.24 | 4.56 % | $ 17.7 M | Nasdaq Global Select Market | ||
|
BeyondSpring
BYSI
|
$ 0.56 | 3.09 % | $ 23 M | Nasdaq Capital Market | ||
|
Capricor Therapeutics
CAPR
|
$ 6.71 | 10.32 % | $ 312 M | Nasdaq Capital Market | ||
|
Oncolytics Biotech
ONCY
|
$ 0.5 | 1.75 % | $ 47.9 M | Nasdaq Global Select Market | ||
|
Outlook Therapeutics
OTLK
|
$ 0.49 | 0.04 % | $ 17.1 M | Nasdaq Global Select Market | ||
|
Protagonist Therapeutics
PTGX
|
$ 128.75 | 0.2 % | $ 8.19 B | Nasdaq Global Select Market | ||
|
Passage Bio
PASG
|
$ 3.5 | 4.44 % | $ 11.2 M | Nasdaq Global Select Market | ||
|
Forte Biosciences
FBRX
|
$ 76.99 | 0.03 % | $ 997 M | Nasdaq Capital Market | ||
|
Mirum Pharmaceuticals
MIRM
|
$ 80.14 | 3.04 % | $ 4.02 B | Nasdaq Global Select Market | ||
|
Inhibikase Therapeutics
IKT
|
$ 1.65 | 1.67 % | $ 162 M | Nasdaq Capital Market | ||
|
Immatics N.V.
IMTX
|
$ 6.73 | 2.0 % | $ 823 M | Nasdaq Global Select Market | ||
|
Immunic
IMUX
|
$ 6.97 | 0.56 % | $ 1.09 B | Nasdaq Global Select Market | ||
|
Immunovant
IMVT
|
$ 26.73 | 0.57 % | $ 4.88 B | Nasdaq Global Select Market | ||
|
MediciNova
MNOV
|
$ 1.42 | 0.69 % | $ 69.7 M | Nasdaq Global Market | ||
|
Iovance Biotherapeutics
IOVA
|
$ 13.62 | 3.59 % | $ 4.87 M | Nasdaq Global Market,SPB | ||
|
Rezolute
RZLT
|
$ 3.58 | 0.12 % | $ 372 M | Nasdaq Capital Market | ||
|
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.